Bristol Myers Squibb Reports Strong Q4 2025 Results, Driven by Immuno-Oncology Treatments
Feb 5, 2026
Bristol Myers Squibb announced its financial results for the fourth quarter and full year of 2025. The company reported fourth-quarter revenue of $12.5 billion, slightly higher than the same period last year and above analyst expectations.
The increase in revenue was mainly supported by growth in sales of the company's immuno-oncology treatments, which helped counterbalance lower revenue from some older drugs.
For the full year 2025, Bristol Myers Squibb recorded revenue of $48.2 billion. Looking ahead, the company provided an optimistic outlook for 2026, which contributed to a rise in its stock price following the announcement.
What helped Bristol Myers Squibb grow its revenue this quarter?
Sales of the company's immuno-oncology treatments increased, helping to boost revenue despite declines in some older drugs.
How did Bristol Myers Squibb's financial results compare to expectations?
The company's fourth-quarter revenue of $12.5 billion was higher than analysts had expected.
Why did Bristol Myers Squibb's stock price go up after the announcement?
The company's positive outlook for 2026 and better-than-expected results encouraged investors.
Sources
Bristol Myers Squibb Revenue Ticks Up on Immuno-Oncology Growth
WSJ
WSJ
Bristol Myers Squibb reported higher fourth-quarter revenue as growth in sales of its immuno-oncology treatments helped to offset a decline in revenue for some of its older drugs.
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for...
Business Wire
Business Wire
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025.
Bristol Myers Stock Rises. Why Fourth-Quarter Earnings Are Exciting Investors.
Barrons
Barrons
Bristol Myers Squibb issues an especially upbeat outlook for 2026.
Bristol Myers Flags Data-Rich 2026 After Solid Quarter
Benzinga
Benzinga
Bristol Myers Squibb & Co. (NYSE: BMY) reported fourth-quarter 2025 revenues of $12.50 billion on Thursday, beating the consensus of $12.281 billion, a 1% increase year over year.
Bristol Myers Just Crushed Earnings, and the Real Catalyst Hasn't Even Hit Yet
24/7 Wall Street
24/7 Wall Street
Bristol Myers Squibb (NYSE:BMY) reported Q4 2025 revenue of $12.5 billion, essentially flat year-over-year, with full-year 2025 revenue reaching $48.2 billion.
Bristol Myers Rises Inside A Buy Zone On Street-Beating 2026 Outlook
Investors Business Daily
Investors Business Daily
Bristol Myers Squibb stock rose moderately Thursday on better-than-expected fourth-quarter metrics and a strong 2026 outlook.
Bristol-Myers Stock Up as Q4 Earnings and Revenues Beat Estimates
Zacks Investment Research
Zacks Investment Research
BMY beats Q4 earnings and revenue estimates as its Growth Portfolio jumps 16%, lifting shares despite continued declines in legacy drugs.
Dow Tumbles Over 400 Points; Bristol Myers Reports Strong Q4 Results
Benzinga
Benzinga
Bristol Myers Squibb & Co. (NYSE:BMY) reported better-than-expected results for the fourth quarter.
What Happened To Boston Scientific Stock?
Forbes
Forbes
Boston Scientific (BSX), a leading global player in medical devices, announced solid Q4 earnings but offered 2026 guidance that slightly fell short of elevated investor expectations. This response was marked by a drastic, high-volume liquidation event that quickly erased months of gains.
Why Bristol Myers Squibb Stock Topped the Market Today
The Motley Fool
The Motley Fool
Investors were impressed by the company's performance in the final quarter of 2025. It beat analyst expectations on both the top and bottom lines.
Bristol-Myers Squibb Company (BMY) Q4 2025 Earnings Call Transcript
Seeking Alpha
Seeking Alpha
Bristol-Myers Squibb Company (BMY) Q4 2025 Earnings Call Transcript
Bristol Myers Squibb CEO: Richest product pipeline we've had in the last decade
CNBC Television
CNBC Television
Chris Boerner, Bristol Myers Squibb CEO, joins CNBC's "Power Lunch" to discuss the company's quarterly earnings results, the drug pipeline and much more.
Biogen Stock Rises Even as Multiple Sclerosis Revenue Tumbles. It Sees Continued...
Barrons
Barrons
Biogen says it expects revenue to fall in 2026 as its multiple sclerosis therapies continue to struggle.
Related Posts
Other News
Corporate Moves
View All
Goldman Sachs Top Lawyer Kathy Ruemmler Resigns After Epstein Email Revelations
3 hours ago
GS
-3.52%
Kathy Ruemmler, the top lawyer at Goldman Sachs, will resign following the release of documents showing her close relationship with Jeffrey Epstein. The documents, made public by the U.S. Department o...
AST SpaceMobile Announces $1 Billion Convertible Note Offering; Plans Note Repurchases as Stock Falls
17 hours ago
ASTS
-16.12%
AST SpaceMobile, a company building a space-based cellular broadband network, has announced it is raising $1 billion through a private offering of convertible senior notes due in 2036. This means the...
CarMax Appoints Keith Barr as New CEO Amid Turnaround Efforts
18 hours ago
KMX
-10.8%
CarMax has announced that Keith Barr, former chief executive of IHG Hotels & Resorts, will become the company's new President and CEO. Barr is set to officially take the role on March 16, 2026, and wi...
Product Launches
View All
Amazon Pharmacy to Expand Same-Day Prescription Delivery to 4,500 U.S. Cities and Towns
Feb 11, 2026
AMZN
-2.56%
Amazon Pharmacy announced it will expand its same-day delivery service for prescription medications to nearly 4,500 cities and towns in the United States by the end of the year. This move will add alm...
Hims & Hers Health Launches $49 Compounded Wegovy Pill Alternative
Feb 5, 2026
HIMS
-5.69%
Hims & Hers Health, an online telehealth company, has announced that it will start offering a compounded version of the popular Wegovy weight loss pill for $49 per month. This price is about $100 less...
Amazon Expands AI Integration with Alexa+ Launch and Media Production Tools
Feb 4, 2026
AMZN
-2.56%
Amazon has made its AI-powered digital assistant, Alexa+, available to all users in the United States. Previously, Alexa+ was in an early access phase, requiring consumers to join a waitlist or purcha...
Regulatory Actions
View All
FDA Refuses to Review Moderna's Flu Vaccine Application
Feb 10, 2026
MRNA
-1.83%
Moderna announced that the U.S. Food and Drug Administration (FDA) has refused to review its application for an experimental flu shot, known as mRNA-1010. The FDA issued a Refusal-to-File (RTF) letter...
EU Moves Against Meta Over Blocking Rival AI Assistants on WhatsApp
Feb 9, 2026
META
-2.51%
The European Union (EU) has charged Meta Platforms, the owner of WhatsApp, with breaking antitrust rules by blocking rival artificial intelligence (AI) assistants from its messaging app WhatsApp.
The...
Hims & Hers Stops Selling Compounded Weight-Loss Pill After FDA Warning
Feb 8, 2026
HIMS
-5.69%
Hims & Hers has decided to stop offering its compounded semaglutide weight-loss pill. This decision came after the U.S. Food and Drug Administration (FDA) said it would take action against the company...
Earnings
View All
Arista Networks Shares Surge After Strong Q4 Results and Positive 2025 Outlook
9 hours ago
ANET
-3.64%
CSCO
-13.12%
Arista Networks reported its financial results for the fourth quarter and full year ending December 31, 2025. The company exceeded Wall Street expectations for both earnings and sales in the last quar...
Pinterest Reports Higher Revenue and Record Users, But Issues Weak Outlook for Next Quarter
13 hours ago
PINS
-2.02%
Pinterest released its fourth-quarter and full-year 2025 financial results, showing revenue growth and record user numbers. In the fourth quarter, revenue rose 14% from the prior year to $1.32 billion...
Rivian Forecasts Delivery Growth Despite Widening Losses in Fourth Quarter 2025
14 hours ago
RIVN
-4.82%
Rivian Automotive reported its financial results for the fourth quarter and full year 2025, showing a 45% decline in automotive revenue to $839 million for the quarter. The company also stated that it...
Stock Movements
View All
Apple Stock Drops After Reports of Siri Upgrade Delays
14 hours ago
AAPL
-5.33%
Apple's stock dropped nearly 4% on Thursday after reports surfaced that the company is delaying the release of its upgraded, AI-powered Siri assistant. The planned upgrades to Siri, expected to bring...
ICON plc Shares Drop Sharply After Accounting Investigation and Earnings Delay
15 hours ago
ICLR
-39.55%
Shares of ICON plc, a company that conducts clinical research, fell by nearly 49% on February 12, 2026. This sharp decline came after the company announced it is delaying its fourth quarter and full y...
Amazon Stock Falls After $200 Billion AI Investment Plan Announced
Feb 12, 2026
AMZN
-2.56%
Amazon.com shares have dropped sharply after the company announced plans to invest $200 billion in artificial intelligence (AI) infrastructure by 2026. The news triggered Amazon's steepest stock decli...
Economy
View All
FedEx Sets Ambitious Growth Targets at 2026 Investor Day
18 hours ago
FDX
+0.65%
FedEx has shared its growth plans at its 2026 Investor Day, aiming to strengthen its leadership as a key player in the global shipping industry. The company announced a strategy that focuses on growin...
U.S. Retail Sales Remain Flat in December, Missing Expectations
Feb 10, 2026
Retail sales in the United States did not grow in December, according to the latest report from the Census Bureau. Sales were unchanged from the previous month, following a 0.6% increase in November....
Private Sector Adds 22,000 Jobs in January, Falling Short of Expectations
Feb 4, 2026
The ADP National Employment Report showed that private sector employment in the United States grew by 22,000 jobs in January 2026. This was lower than many analysts had expected, with forecasts antici...
Analyst Ratings
View All
Nvidia Shares Rise as Analysts Boost Outlook Ahead of Earnings Report
22 hours ago
NVDA
-1.53%
Nvidia's stock rose about 1.5% to $191.84 on Wednesday, outperforming the broader market. This increase follows an analyst upgrade, which highlighted continued optimism about Nvidia's performance in a...
Oracle Stock Rebounds After Analyst Upgrade and AI Concerns Ease
Feb 9, 2026
ORCL
+0.14%
Oracle shares have recently faced a significant decline, dropping over 13% in the past five trading days. The downturn was driven by worries about the company's large investments in artificial intelli...
Microsoft Stock Faces Downgrade Amid Growing AI Competition
Feb 6, 2026
MSFT
-0.41%
Microsoft's stock has recently faced pressure after receiving a downgrade from Stifel, which cited increasing competition in artificial intelligence from companies like Google and Anthropic. The downg...
Mergers & Acquisitions
View All
Nuveen to Acquire U.K. Asset Manager Schroders in $13.5 Billion Deal
Feb 12, 2026
SDR
-0.51%
U.S.-based asset manager Nuveen has agreed to buy the British investment firm Schroders for approximately £9.9 billion (about $13.5 billion), according to announcements from both companies. The acquis...
Paramount Increases Offer for Warner Bros. Discovery with Added Shareholder Benefits
Feb 10, 2026
WBD
-0.25%
PARA
-6.04%
Paramount has revised its $30 per share, all-cash offer for Warner Bros. Discovery (WBD) by adding new incentives for WBD shareholders. The new terms include a $0.25 per share 'ticking fee,' which wil...
Transocean to Acquire Valaris in $5.8 Billion All-Stock Deal
Feb 10, 2026
RIG
-0.5%
VAL
-0.58%
Transocean has agreed to acquire its competitor Valaris in an all-stock transaction valued at approximately $5.8 billion. The combined company will become the world's largest and most advanced offshor...
IPO
View All
Once Upon a Farm, Co-Founded by Jennifer Garner, Raises Nearly $198 Million in IPO
Feb 6, 2026
Once Upon a Farm, an organic children's food company co-founded by actress Jennifer Garner, has successfully gone public in the United States. The company raised nearly $198 million in its initial pub...
Bob's Discount Furniture Raises $330.7 Million in NYSE Debut
Feb 5, 2026
AAAGY
Bob's Discount Furniture has raised $330.7 million through its initial public offering (IPO) in the United States. The company's shares were priced at $17 each. In total, 19,450,000 shares were offere...
EquipmentShare Raises $747 Million in Nasdaq Debut, Valued Over $7 Billion
Jan 23, 2026
EquipmentShare.com Inc, a leading provider of equipment rentals and construction technology, has completed its initial public offering (IPO). The company offered 30,500,000 shares of its Class A commo...
